How AI-Driven Multi-Omics is Reshaping Drug Discovery
The fusion of artificial intelligence (AI) with multi-omics - a comprehensive study encompassing genomics, transcriptomics, proteomics, metabolomics, and other related …
All Posts
VRG50635, a Drug Discovered Through Verge Genomics' AI-powered planform, Shows Promising Phase 1 Results for ALS Treatment
Verge Genomics, a frontrunner in the implementation of AI in drug discovery, recently concluded the Phase 1 clinical trial of …
How to Discover a Preclinical Drug Candidate in Two Years
Recent advances in artificial intelligence (AI) has played a pivotal role in optimizing the small-molecule synthesis, standardization, scalability and CRO-based …
IgGenix Advances Therapeutic Approach to Peanut Allergies with IgG4 Monoclonal Antibodies
IgGenix, Inc., a California-based preclinical antibody discovery and development company, recently reported advances towards a potential therapeutic solution for peanut …
Dr. James Field on Breaking the 'Cognition Barrier' in Antibody Discovery with AI and Robotics
We're fortunate to speak with Dr. James Field, founder and CEO of LabGenius, a leading machine learning (ML)-driven protein engineering …
Collaborative Open-Source Approaches Are the New Norm in Life Sciences Research, According to Survey
Life sciences research has experienced significant shifts in its operational paradigms in recent years, driven largely by the advent and …
How AI Enables Precision Oncology
Lantern Pharma’s AI-driven drug discovery platform RADR® enables value creation across multiple dimensions of the oncology drug development process: from …
The Rising Role of AI-enabled Digital Pathology in Drug Discovery
The field of pathology has experienced a major shift over the past few decades. This evolution began as early as …
Harnessing AI for Drug Discovery Certara Amplifies CODEX Platform Capabilities
Certara, a leader in biosimulation, has recently expanded the horizons of AI in drug discovery with the introduction of artificial …
Collaboration Between Iktos and Curreio Harnesses AI and Cryo-EM for Drug Discovery
Iktos, a French AI-focused company specializing in new drug design, and Curreio, a Japanese cryo-electron microscopy (cryo-EM) expert, have recently …
CEPI and aVaxziPen Partner to Advance Needle-Free Vaccine Delivery Aiming for Equitable Global Access
Needle-free vaccine delivery has emerged as a promising solution to overcome the challenges associated with frozen storage requirements, thereby improving …
BenevolentAI Pioneers AI-Driven Drug Discovery for ALS Treatment
Incorporating AI in drug discovery is rapidly becoming a common practice in the pharmaceutical industry. The recent undertakings of UK-based …